Boehringer Ingelheim

News

NICE says Boehringer stroke drug 'could save millions'

In new guidance, NICE has cleared NHS use of Boehringer Ingelheim's clot-busting therapy Metalyse as a treatment for acute ischaemic stroke in adults.

News

Boehringer backs Brainomix AI software for lung fibrosis

Boehringer Ingelheim has joined forces with digital health firm Brainomix on a project to improve the care of people with fibrosing lung diseases in the US.

News

Judge kicks out another Medicare price negotiation challenge

A Connecticut federal judge has sided with the US Department of Health and Human Services (HHS) in Boehringer Ingelheim's challenge to Medicare’s drug price negotiation programme, rejecting

News

GSK et al file appeal to Delaware Zantac order

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead.

News

Boehringer, Lilly face off in MASH at EASL

Drugs from Eli Lilly and Boehringer Ingelheim grabbed the spotlight at the EASL congress on liver diseases, both showing promising results in metabolic dysfunction-associa

News

Boehringer raises hope of diabetic macular ischaemia therapy

Boehringer Ingelheim says it may have found the first therapy for diabetic macular ischaemia (DMI), a common and irreversible complication of the eye in people with diabet

NICE says Boehringer stroke drug 'could save millions'

Boehringer backs Brainomix AI software for lung fibrosis

Judge kicks out another Medicare price negotiation challenge

GSK et al file appeal to Delaware Zantac order

Boehringer, Lilly face off in MASH at EASL

Boehringer raises hope of diabetic macular ischaemia therapy

UK body raps Sanofi for disparaging Pfizer's RSV jab

How to meet your physicians where they are online

Boehringer Ingelheim

Editor's Picks